Mitochondrial Cytopathies Disorders
Conditions
Brief summary
The aim of the present study is to compare Resting Energy Expenditure (REE) between normal fat diet (NFD) as a control vs high fat diet (HFD) as a treatment in Mitochondrial cytopathies disorders ( MID's ) patients. Secondary objectives is to compare diet induced thermogenesis (DIT) and body composition between NFD vs HFD. This study is a randomized cross-over study. Normal fat diet (ie 10 % proteins, 45 % lipids, 45 % carbohydrates) is the imposed diet at baseline, high fat diet (ie 10 % proteins, 30 % lipids, 60 % carbohydrates is used according to the cross-over design trial. Main evaluation criteria is REE and second evaluation criteria is DIT both measured by indirect calorimetry ). 36 included MID subjects will be included in this study. Main evaluation criteria and second evaluation criteria will be measured at baseline, 1 month, 2 month and 3 month.
Detailed description
REE and DIT are measured by indirect calorimetry . The device used is a using an open-circuit ventilated hood system (QUARK RMR®, Cosmed, Pavona; Italy). The respiration quo- tient (RQ) and flow settings are calibrated by reference to alcohol combustion every six months. Before each test, the calorimeter is calibrated with a reference gas mixture (5% CO2, 95% O2 v/v). Expired carbon di- oxide (VCO2) and inspired oxygen (VO2) -flows are recorded, as well as the RQ. EE is calculated every minute from oxygen consumption (VO2 in ml/min) and carbon dioxide production (VCO2 in ml/min) using the Weir formula without protein correction. DIT is measured during 6 hours after a calibrated breakfast (normal fat diet or high fat diet according to the cross-over design) as 30% of theoric energy intake.
Interventions
OTHERhigh fat diet
high fat diet as 10 % proteins, 30 % lipids, 60 % carbohydrates
OTHERnormal fat diet
high fat diet as 10 % proteins, 45 % lipids,45 % carbohydrates
Sponsors
Ministry of Health, France
University Hospital, Lille
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
No
Inclusion criteria
* 5 to 21 years-old children, * Children with a proven mitochondrial cytopathy documented on biopsies by histology, histoenzymology, ultrastructure and enzyme assay and/or on body fluids by laboratory markers including lactacidemia, metabolic acidosis, increased CSF lactate, lactate/pyruvate and beta-hydroxybutyrate/acetoacetate ratios, paradoxical postprandial ketonemia, alaninemia, citrullinemia, plasma acylcarnitines. * Children on the usual diet (30% lipids, 60% glucides and 10% proteins) for at least 1 month. * Informed consent of the 2 parents and from the child when in age to express a consent. * Child with a social security cover.
Exclusion criteria
* Acute infection (fever \> 38.5°C for more than 6h) within 7 days prior to the study. * Disability for understanding and following the protocol * Rejection of the study by the patient or failure to comply to the protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| resting energy expenditure | up to 3 months | resting energy expenditure measured by indirect calorimetry |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| diet induced thermogenesis | baseline, 1 month, 2 months, 3 months | diet induced thermogenesis measured by indirect calorimetry |
| body composition | baseline, 1 month, 2 months, 3 months | body composition by DEXA |
Countries
France
Outcome results
None listed